Results 21 to 30 of about 1,185 (135)

Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania [version 1; peer review: 3 approved] [PDF]

Wellcome Open Research, 2019
Introduction: Substandard and falsified medicines undermine health systems. We sought to unravel the political and economic factors which drive the production of these products, and to explain how they reach patients.
Elizabeth Pisani, Adina-Loredana Nistor, Amalia Hasnida, Koray Parmaksiz, Jingying Xu, Maarten Oliver Kok   +5 more
doaj   +2 more sources

Prevalence of Unregistered, Substandard, and Falsified Veterinary Antimicrobials in Ethiopia: A National Postmarket Quality Surveillance Study. [PDF]

Vet Med Int
Background The proliferation of unregistered, substandard, and falsified (SF) veterinary pharmaceuticals represents a critical global threat to animal health, food security, and environmental conservation. In sub‐Saharan Africa, these products exacerbate the emergence of antimicrobial resistance (AMR), potentially accelerating the transition toward a ...
Tefera B, Bacha B, Tefera N, Uma G, Setegn T, Belete B, Daba D, Jemal D, Tefera Y, Bedu H, Tilki T, Hailemichael D, Kebede S, Jemal H, Marew T, Teshome D, Gedif T, Gelaye E, Andualem T, Ashenef A.   +19 more
europepmc   +2 more sources

Artemisinin-Based Combination Therapies in East Africa: A Systematic Review of Quality, Clinical Efficacy, and Regulatory Progress Towards Sustainable Malaria Control. [PDF]

Trop Med Int Health
ABSTRACT Background Malaria is a major public health issue in East Africa, leading to widespread illness and fatalities, especially among vulnerable populations such as children under 5 years of age and pregnant women. Artemisinin‐based combination therapies (ACTs) are the primary treatment modality; however, their efficacy is undermined by the ...
Mekasha YT, Tegegne AA, Mashe T, Girma M, Hasen G, Belew S.   +5 more
europepmc   +2 more sources

The urgent need for African research collaboration on medicine quality [PDF]

Nature Communications
Substandard and falsified medicines threaten African health systems, yet research on this crisis is fragmented and concentrated in few countries, predominantly led by Global North institutions.
Fanqi Zeng, Simon Mariwah, Gerry Mshana, Daniel Amoako-Sakyi, Heather Hamill   +4 more
doaj   +2 more sources

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study

PLoS ONE, 2023
The prevalence of substandard and falsified medicines in low- and middle-income countries (LMICs) is a major global public health concern. Multiple screening technologies for post-market surveillance of medicine quality have been developed but there ...
Colleen R. Higgins, Betty Kobia, Sachiko Ozawa   +2 more
doaj   +2 more sources

Community pharmacy professionals’ knowledge, attitudes, and practices toward substandard and falsified medicines and associated factors in Bahir Dar City, Northwest Ethiopia [PDF]

Frontiers in Pharmacology
Yeniewa Kerie Anagaw, Biset Asrade Mekonnen, Minichil Worku   +2 more
exaly   +2 more sources

Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries

Frontiers in Medicine, 2022
IntroductionThe presence of N-nitrosamine impurities in medicines raised concerns globally as they are genotoxic and probable human carcinogens. A review of N-nitrosamine impurities in medicines provides an opportunity for National Regulatory Authorities
Patience P. Shabangu, Rutendo J. Kuwana, Admire Dube   +2 more
doaj   +1 more source

Screening for substandard and falsified medicines in Nigeria using visual inspection and GPHF-Minilab analysis: lessons learnt for future training of health workers and pharmacy personnel [PDF]

Journal of Pharmaceutical Policy and Practice
Lutz Heide
exaly   +2 more sources

Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries. [PDF]

Am J Trop Med Hyg, 2021
ABSTRACTSubstandard and falsified medicines have severe public health and socioeconomic effects, especially in low- and middle-income countries. The WHO has emphasized the need for reliable estimates of the prevalence of such medicines to efficiently respond to this problem.
Hauk C, Hagen N, Heide L.
europepmc   +4 more sources

Antimicrobial Resistance and Substandard and Falsified Medicines: The Case of HIV/AIDS. [PDF]

J Infect Dis, 2019
Suthar AB, Coggin W, Raizes E.
europepmc   +4 more sources